Domain Therapeutics' Grant

Domain Therapeutics raised a round of funding on January 09, 2012. Investors include The Michael J. Fox Foundation.

Domain Therapeutics, formerly Faust Pharmaceuticals, is a biopharmaceutical company dedicated to the discovery and early development of small molecules targeting G-Protein Coupled Receptors (GPCRs). D…

Articles about Domain Therapeutics' Grant: